Case in point
US pharma innovator leverages TCS ADD™ Metadata Repository Platform
Overview
A large, innovation-driven US pharmaceutical company transformed its clinical trial submission process by implementing TCS’s AI-powered TCS ADD™ Metadata Repository Platform, setting a new industry benchmark.
Challenges
The company faced several operational challenges, including fragmented standards, manual dataset generation, rising trial volumes, increasing compliance complexity, and limited automation. These issues caused inefficiencies, delayed submissions, and heightened regulatory risks thereby slowing down drug development timelines.
Solution
To address these, TCS implemented its next-generation, AI-powered TCS ADD™ Metadata Repository, a comprehensive platform that transforms the way clinical standards metadata, study metadata and transformation specs is managed, standardized, and submitted.
The platform included advanced AI and cognitive automation modules that helped automate the creation of submission-ready SDTM and ADaM datasets. As a foundation, the TCS ADD™ platform deployed a clinical standards metadata registry that manages metadata across the clinical data lifecycle. This included source data collection, SDTM, ADaM, ARS, controlled terminology, and lab standards—with traceability, transformation specs and version control. Smart governance and real-time monitoring ensured flexibility across different study scenarios while maintaining control and quality.
Key results:
Automation at scale:
- Achieved 96% automation in SDTM generation across 70+ domains and 81% in ADaM variable allowing for quick, repeatable, and scalable data transformation.
Accelerated timelines:
- Reduced statistical programming efforts by over 65% and saved 8,100 business hours in the first year alone.
- Compressed SDTM creation from 30 days to 3 (10X) and reduced a six-week, four developer process to just three days (15X), two resource operations.
Regulatory confidence:
- Enabled 100+ transformation types and instant onboarding of Clinical Data Interchange Standards Consortium (CDISC) standards.
This enterprise-wide transformation not only redefined the sponsor's clinical data submission approach but also set a new standard for the pharmaceutical industry’s digital evolution.